These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10064202)

  • 1. Fetal fibronectin as a predictor of preterm birth: an overview.
    Revah A; Hannah ME; Sue-A-Quan AK
    Am J Perinatol; 1998; 15(11):613-21. PubMed ID: 10064202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal fibronectin--how useful is it in the prediction of preterm birth?
    Leitich H; Kaider A
    BJOG; 2003 Apr; 110 Suppl 20():66-70. PubMed ID: 12763115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Blind" vaginal fetal fibronectin as a predictor of spontaneous preterm delivery.
    Roman AS; Koklanaris N; Paidas MJ; Mulholland J; Levitz M; Rebarber A
    Obstet Gynecol; 2005 Feb; 105(2):285-9. PubMed ID: 15684153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of rapid fetal fibronectin in predicting preterm delivery.
    Tekesin I; Marek S; Hellmeyer L; Reitz D; Schmidt S
    Obstet Gynecol; 2005 Feb; 105(2):280-4. PubMed ID: 15684152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of fetal fibronectin for predicting preterm birth.
    Swamy GK; Simhan HN; Gammill HS; Heine RP
    J Reprod Med; 2005 Nov; 50(11):851-6. PubMed ID: 16419634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
    Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L
    BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal fetal fibronectin as a predictor of spontaneous preterm delivery after multifetal pregnancy reduction.
    Roman AS; Rebarber A; Lipkind H; Mulholland J; Minior V; Roshan D
    Am J Obstet Gynecol; 2004 Jan; 190(1):142-6. PubMed ID: 14749650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Will cervicovaginal interleukin-6 combined with fetal fibronectin testing improve the prediction of preterm delivery?
    LaShay N; Gilson G; Joffe G; Qualls C; Curet L
    J Matern Fetal Med; 2000; 9(6):336-41. PubMed ID: 11243290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is fetal fibronectin a valid test predictive of premature labor?].
    Mansouri A; Tadjerouni A; El Rabiey G; Baube S; Garnier G; Tribalat S
    Contracept Fertil Sex; 1997 May; 25(5):380-4. PubMed ID: 9273109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
    Incerti M; Ghidini A; Korker V; Pezzullo JC
    Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fetal fibronectin and cervical length as early predictors of preterm labor].
    López Farfán JA; Sánchez Tovar HB; Gutiérrez de Anda Mdel R; Gámez Guevara C
    Ginecol Obstet Mex; 2011 Jun; 79(6):337-43. PubMed ID: 21966824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervico-vaginal fetal fibronectin: predictive value during false labor.
    Langer B; Boudier E; Schlaeder G
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):218-21. PubMed ID: 9093134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of fetal fibronectin to predict preterm birth in twin gestations with symptoms of labor.
    Singer E; Pilpel S; Bsat F; Plevyak M; Healy A; Markenson G
    Obstet Gynecol; 2007 May; 109(5):1083-7. PubMed ID: 17470586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome in women with preterm labor symptoms without cervical change.
    Rinehart BK; Terrone DA; Isler CM; Barrilleaux PS; Bufkin L; Morrison JC
    Am J Obstet Gynecol; 2001 Apr; 184(5):1004-7. PubMed ID: 11303212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New biomarkers for the prediction of spontaneous preterm labour in symptomatic pregnant women: a comparison with fetal fibronectin.
    Liong S; Di Quinzio MK; Fleming G; Permezel M; Rice GE; Georgiou HM
    BJOG; 2015 Feb; 122(3):370-9. PubMed ID: 25056135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal fibronectin test predicts delivery before 30 weeks of gestation in high risk women, but increases anxiety.
    Shennan A; Jones G; Hawken J; Crawshaw S; Judah J; Senior V; Marteau T; Chinn S; Poston L
    BJOG; 2005 Mar; 112(3):293-8. PubMed ID: 15713142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fetal fibronectin as a marker of prematurity in a high risk patient sample].
    Surbek D; Bösiger H; Pavic N; Huber P; Almendral AC; Holzgreve W
    Z Geburtshilfe Neonatol; 1997; 201(1):15-20. PubMed ID: 9172901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal fibronectin in patients at increased risk for premature birth.
    Vĕtr M; Kudela M; Prásilová J
    Acta Univ Palacki Olomuc Fac Med; 1996; 140():55-7. PubMed ID: 9431693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal fibronectin and bacterial vaginosis are associated with preterm birth in women who are symptomatic for preterm labor.
    Stevens AO; Chauhan SP; Magann EF; Martin RW; Bofill JA; Cushman JL; Morrison JC
    Am J Obstet Gynecol; 2004 Jun; 190(6):1582-7; discussion 1587-9. PubMed ID: 15284741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador.
    Díaz J; Chedraui P; Hidalgo L; Medina M
    J Matern Fetal Neonatal Med; 2009 Feb; 22(2):89-93. PubMed ID: 19085632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.